MedTrace Logo

Understanding Changes in Heart Function After Exercise in People With Stroke

NCT01189045 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2017-05-10

No results posted yet for this study

Summary

Little is known about how exercise can affect heart function in stroke survivors.

This study will look at changes in cardiovascular fitness and function after 6 months of exercise. Volunteers will be tested before and after the program and again 2 months later to measure the effects on stroke risk factors, fitness level and flexibility of the arteries. Blood tests will measure cholesterol levels and other signs of inflammation.

This study will help us better understand how exercise after stroke can improve heart function and heart health, and ultimately help in lowering future stroke risk.

Conditions

Interventions

BEHAVIORAL

Aerobic Exercise Program

The AEROBIC PROGRAM will be the Experimental arm of this trial. It will be a structured, progressive aerobic training program that will be 6 months in duration. Classes will be held 3 times / week, for 1 hour / session.

BEHAVIORAL

Non-aerobic Exercise Program

The BALANCE AND FLEXIBILITY (non-aerobic) PROGRAM will be the Active Comparator arm of this trial. It will be comprised of upper and lower body stretching, or balance activities, yoga- or Tai Chi-style classes. This program will be 6 months in duration. Classes will be held 3 times / week, for 1 hour / session.

Sponsors & Collaborators

  • University of British Columbia

    lead OTHER

Principal Investigators

  • Janice Eng, PhD · The University of British Columbia - Vancouver Coastal Health Research Institute

  • Penelope Brasher, PhD · Vancover General Hospital

  • Andrei Krassioukov, MD, PhD · University of British Columbia

  • Kenneth Madden, MD · University of British Columbia

  • Ada Tang · University of British Columbia

  • Teresa Tsang, MD · University of British Columbia

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
50 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-09-30
Primary Completion
2011-10-31
Completion
2012-04-30

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01189045 on ClinicalTrials.gov